# Lonza Biologics, Inc. – FDA Inspection, Jul 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/fa6c0e5e-762e-44f9-b5cd-483c8003242f
Source feed: FDA_Inspections

> FDA inspection 1210690 of Lonza Biologics, Inc., July 21, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210690
- Company Name: Lonza Biologics, Inc.
- Inspection Date: 2023-07-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1312718 - 2026-04-16](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/5bbfa47f-509d-40b8-bed0-301a8269c65e)
- [FDA Inspection 1304046 - 2026-02-06](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/f423c98c-ca42-48ca-aa3a-6cfd4e863518)
- [FDA Inspection 1269735 - 2025-06-06](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/764dd13f-c7b5-4dc4-a6d1-c66b08767132)
- [FDA Inspection 1246345 - 2024-07-12](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/f5daf7e2-8fee-4f83-b20e-a0a824ab2a8c)
- [FDA Inspection 1232144 - 2024-03-07](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/d26d327b-7e5e-44dc-a11f-5a0ed641f62d)

## Related Officers

- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)

Company: https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c